Literature DB >> 7316885

Discrimination of level differences by hearing-impaired patients.

H Fastl, K Schorn.   

Abstract

A technique for measuring the discrimination of level differences with pulsed tones is proposed. Alternating tone bursts, each of 500 ms duration but of different sound pressure levels, are separated by 200-ms pauses. The advantages of this method in comparison with traditional methods (SISI test, Lüscher-Zwislocki test) which use modulated tones are that level discrimination is independent of frequency and that it shows very little dependence on sensation level. With this technique, the level discrimination of patients with conductive hearing loss, 'toxic' hearing impairment, noise-induced hearing loss, sudden deafness, presbyacusis, Meniere's disease, and retrocochlear impairment was determined and compared to the results obtained in normal ears. Using the level discrimination test proposed, retrocochlear disorders can be diagnosed with great reliability.

Entities:  

Mesh:

Year:  1981        PMID: 7316885     DOI: 10.3109/00206098109072717

Source DB:  PubMed          Journal:  Audiology        ISSN: 0020-6091


  4 in total

1.  Level discrimination of speech sounds by hearing-impaired individuals with and without hearing amplification.

Authors:  William M Whitmer; Michael A Akeroyd
Journal:  Ear Hear       Date:  2011 May-Jun       Impact factor: 3.570

2.  Partial masking in electrocutaneous sensation: a model for sensation matching, with applications to loudness recruitment.

Authors:  W D Larkin; M J Penner
Journal:  Percept Psychophys       Date:  1989-09

3.  Rinne test: does the tuning fork position affect the sound amplitude at the ear?

Authors:  Oleksandr Butskiy; Denny Ng; Murray Hodgson; Desmond A Nunez
Journal:  J Otolaryngol Head Neck Surg       Date:  2016-03-24

4.  Impact of reducing the duration of antibiotic treatment on the long-term prognosis of community acquired pneumonia.

Authors:  Ane Uranga; Amaia Artaraz; Amaia Bilbao; Jose María Quintana; Ignacio Arriaga; Maider Intxausti; Jose Luis Lobo; Julia Amaranta García; Jesus Camino; Pedro Pablo España
Journal:  BMC Pulm Med       Date:  2020-10-07       Impact factor: 3.317

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.